1 study found for:    18190254 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals’ EBV (Epstein Barr Virus) Vaccine (268664).
Condition: Epstein Barr Virus (EBV) Infection
Intervention: Biological: EBV vaccine (268664)

Indicates status has not been verified in more than two years